This study investigates the use of autologous umbilical cord blood in newborns with Hypoxic-Ischemic Encephalopathy (HIE), a condition where the brain does not receive enough oxygen and blood. The study aims to see if this treatment can improve outcomes for these newborns who are also receiving a cooling therapy called therapeutic hypothermia.
Participants in the study will receive their own umbilical cord blood. This involves collecting the blood from the umbilical cord right after birth and using it as a treatment. Therapeutic hypothermia, which is a cooling treatment, will also be administered to help protect the brain.
- Who can participate: The study is open to newborns and infants diagnosed with Hypoxic-Ischemic Encephalopathy (HIE).
- Study details: Participants will have their own umbilical cord blood collected and used as part of the treatment in combination with therapeutic hypothermia.
